Trastuzumab Recruiting Phase 2 Trials for Her-2 Positive Gastric Cancer / Metastatic Cancers Treatment

Indications	Status	Purpose	Phase
DBCOND0053277 (Her-2 Positive Gastric Cancer) DBCOND0060442 (Metastatic Cancers)	Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT03588533	Herzuma-capecitabine/Cisplatin for Gastric Cancer	Trastuzumab (DB00072) Capecitabine (DB01101) Cisplatin (DB00515)